Li Jun, To David, Gunn Vickie, Shi Wenyin, Yu Yan, Liu Haisong
1 Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, PA, USA.
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818802804. doi: 10.1177/1533033818802804.
The study was aimed to compare hybrid arc and volumetric-modulated arc therapy treatment plans for fractionated stereotactic radiotherapy of brain tumors.
Treatment plans of 22 patients were studied. Hybrid arc and volumetric-modulated arc therapy plans were generated using Brainlab iPlanDose and Varian Eclipse treatment planning systems, respectively, with 6 MV photon beams on a Varian TrueBeam STx linear accelerator (Palo Alto, CA). Prescription dose was 54 Gy. The fractionation was 1.8 Gy per fraction and 30 fractions in total, or 2 Gy per fraction and 27 fractions in total. Planning target volume ranged from 2.4 to 28.6 cm. Dose conformity index, gradient index, homogeneity index, and maximum doses in organs at risk were compared. Wilcoxon signed rank test was used to determine statistical significance in paired comparison.
Conformity indexes of hybrid arc and volumetric-modulated arc therapy plans are 1.10 ± 0.10 and 1.14 ± 0.07, respectively ( P = .4); gradient indexes are 5.02 ± 1.20 and 5.64 ± 1.28, respectively ( P = .0001); homogeneity indexes are 1.02 ± 0.01 and 1.05 ± 0.01, respectively ( P = .0001); brainstem maximum doses are 53.87 ± 1.63 Gy and 54.06 ± 3.17 Gy, respectively ( P = .1); and optic chiasm maximum doses are 53.86 ± 1.28 Gy and 53.95 ± 1.81, respectively ( P = .4). The monitor unit efficiencies of hybrid arc and volumetric-modulated arc therapy plans are 2.57 ± 0.25 MU/cGy and 2.68 ± 0.24 MU/cGy, respectively ( P = .2). The differences of conformity index, gradient index, and homogeneity index between hybrid arc and volumetric-modulated arc therapy plans are small: 0.08 ± 0.05, 0.65 ± 0.46, and 0.02 ± 0.01, respectively. The maximum doses in organs at risks are similar between hybrid arc and volumetric-modulated arc therapy plans. Hybrid arc and volumetric-modulated arc therapy plans, which have similar monitor unit efficiencies, present similar dosimetric results in the fractionated intracranial radiotherapy.
本研究旨在比较混合弧形调强放疗(VMAT)和容积弧形调强放疗(VMAT)治疗计划在脑肿瘤分割立体定向放疗中的应用。
研究了22例患者的治疗计划。分别使用Brainlab iPlanDose和Varian Eclipse治疗计划系统生成混合弧形调强放疗(VMAT)和容积弧形调强放疗(VMAT)计划,在Varian TrueBeam STx直线加速器(加利福尼亚州帕洛阿尔托)上使用6 MV光子束。处方剂量为54 Gy。分割方式为每次1.8 Gy,共30次,或每次2 Gy,共27次。计划靶体积范围为2.4至28.6 cm³。比较了剂量适形指数、梯度指数、均匀性指数以及危及器官的最大剂量。采用Wilcoxon符号秩检验确定配对比较中的统计学意义。
混合弧形调强放疗(VMAT)和容积弧形调强放疗(VMAT)计划的适形指数分别为1.10±0.10和1.14±0.07(P = 0.4);梯度指数分别为5.02±1.20和5.64±1.28(P = 0.0001);均匀性指数分别为1.02±0.01和1.05±0.01(P = 0.0001);脑干最大剂量分别为53.87±1.63 Gy和54.06±3.17 Gy(P = 0.1);视交叉最大剂量分别为53.86±1.28 Gy和53.95±1.81(P = 0.4)。混合弧形调强放疗(VMAT)和容积弧形调强放疗(VMAT)计划的监测单位效率分别为2.57±0.25 MU/cGy和2.68±0.24 MU/cGy(P = 0.2)。混合弧形调强放疗(VMAT)和容积弧形调强放疗(VMAT)计划在适形指数、梯度指数和均匀性指数上的差异较小:分别为0.08±0.05、0.65±0.46和0.02±0.01。混合弧形调强放疗(VMAT)和容积弧形调强放疗(VMAT)计划在危及器官的最大剂量方面相似。混合弧形调强放疗(VMAT)和容积弧形调强放疗(VMAT)计划具有相似的监测单位效率,在分割颅内放疗中呈现相似的剂量学结果。